Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease

Background In patients with atherosclerotic cardiovascular disease, increasing age is concurrently associated with higher risks of ischemic and bleeding events. The objectives are to determine the impact of aspirin dose on clinical outcomes according to age in atherosclerotic cardiovascular disease....

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Guillaume Marquis‐Gravel, Amanda Stebbins, Lisa M. Wruck, Matthew T. Roe, Mark B. Effron, Bradley G. Hammill, Jeff Whittle, Jeffrey J. VanWormer, Holly R. Robertson, Jacqueline D. Alikhaani, Sunil Kripalani, Peter M. Farrehi, Saket Girotra, Catherine P. Benziger, Tamar S. Polonsky, J. Greg Merritt, Kamal Gupta, Thomas E. McCormick, Kirk U. Knowlton, Sandeep K. Jain, Ajar Kochar, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, W. Schuyler Jones
स्वरूप: लेख
भाषा:English
प्रकाशित: Wiley 2024-02-01
श्रृंखला:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
विषय:
acetylsalicylic acid
age
aspirin
atherosclerotic cardiovascular disease
coronary artery disease
ऑनलाइन पहुंच:https://www.ahajournals.org/doi/10.1161/JAHA.122.026921

इंटरनेट

https://www.ahajournals.org/doi/10.1161/JAHA.122.026921

समान संसाधन